FDA staff: There could be benefits to J&J booster shot

Wednesday, 13. October 2021 16:44

Scientists from the United States Food and Drug Administration said on Wednesday that there might be benefits to receiving a second Johnson & Johnson COVID-19 vaccine shot at least two months after the first dose.

"Although not independently confirmed by FDA from datasets, summaries of the data suggest there may be a benefit in a second dose administered approximately two months after the primary dose, when compared to the efficacy seen in the pivotal study COV3001," an FDA paper noted.

The FDA's vaccines committee is scheduled to meet in two days in order to discuss the efficacy and safety of Johnson & Johnson booster shots.

Related Links: Johnson & Johnson
Breaking the News / ND